mRNA transcription and activity of Pep T1 have been shown to increase to compensate absorptive capability in patients with short-bowel syndrome chronic ulcerative colitis and with Crohn’s disease (Merlin et al., 2001; Ziegler et al., 2002). This evidence concerns the gene SLC15A1 and Crohn disease.